Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Are FXR Family Proteins Integrators of Dopamine Signaling and Glutamatergic Neurotransmission in Mental Illnesses?
Khlghatyan J, Beaulieu JM.
Front Synaptic Neurosci. 2018 Jul 24;10:22. doi: 10.3389/fnsyn.2018.00022. eCollection 2018. Review.
Similar articles
Mental Illnesses-Associated Fxr1 and Its Negative Regulator Gsk3β Are Modulators of Anxiety and Glutamatergic Neurotransmission.
Khlghatyan J, Evstratova A, Chamberland S, Marakhovskaia A, Bahremand A, Toth K, Beaulieu JM.
Front Mol Neurosci. 2018 Apr 12;11:119. doi: 10.3389/fnmol.2018.00119. eCollection 2018.
Regulation of the Neuroligin-1 Gene by Clock Transcription Factors.
Hannou L, Bélanger-Nelson E, O'Callaghan EK, Dufort-Gervais J, Ballester Roig MN, Roy PG, Beaulieu JM, Cermakian N, Mongrain V.
J Biol Rhythms. 2018 Apr;33(2):166-178. doi: 10.1177/0748730418761236.
The interaction of GSK3B and FXR1 genotypes may influence the mania and depression dimensions in mood disorders.
Bureau A, Beaulieu JM, Paccalet T, Chagnon YC, Maziade M.
J Affect Disord. 2017 Apr 15;213:172-177. doi: 10.1016/j.jad.2017.02.023. Epub 2017 Feb 16.
A dense cluster of D1 + cells in the mouse nucleus accumbens.
Petryszyn S, Sánchez MG, Gagnon D, Beaulieu JM, Parent A, Parent M.
Synapse. 2017 Jan;71(1):51-54. doi: 10.1002/syn.21946. Epub 2016 Nov 10.
Converging evidence for regulation of dopamine neurotransmission by lithium: An Editorial Highlight for 'Chronic lithium treatment rectifies maladaptive dopamine release in the nucleus accumbens'.
Beaulieu JM.
J Neurochem. 2016 Nov;139(4):520-522. doi: 10.1111/jnc.13846. Epub 2016 Oct 18.
Repetitive transcranial magnetic stimulation induces long-lasting changes in protein expression and histone acetylation.
Etiévant A, Manta S, Latapy C, Magno LA, Fecteau S, Beaulieu JM.
Sci Rep. 2015 Nov 20;5:16873. doi: 10.1038/srep16873.
Increased ethanol consumption despite taste aversion in mice with a human tryptophan hydroxylase 2 loss of function mutation.
Lemay F, Doré FY, Beaulieu JM.
Neurosci Lett. 2015 Nov 16;609:194-7. doi: 10.1016/j.neulet.2015.10.045. Epub 2015 Oct 21.
Selective disruption of dopamine D2-receptors/beta-arrestin2 signaling by mood stabilizers.
Del' Guidice T, Beaulieu JM.
J Recept Signal Transduct Res. 2015 Jun;35(3):224-32. doi: 10.3109/10799893.2015.1072976. Epub 2015 Oct 12.
In vivo veritas, the next frontier for functionally selective GPCR ligands.
Methods. 2016 Jan 1;92:64-71. doi: 10.1016/j.ymeth.2015.08.018. Epub 2015 Aug 28. Review.
FXR1P is a GSK3β substrate regulating mood and emotion processing.
Del'Guidice T, Latapy C, Rampino A, Khlghatyan J, Lemasson M, Gelao B, Quarto T, Rizzo G, Barbeau A, Lamarre C, Bertolino A, Blasi G, Beaulieu JM.
Proc Natl Acad Sci U S A. 2015 Aug 18;112(33):E4610-9. doi: 10.1073/pnas.1506491112. Epub 2015 Aug 3.
Differential modulation of Nav1.7 and Nav1.8 channels by antidepressant drugs.
Thériault O, Poulin H, Beaulieu JM, Chahine M.
Eur J Pharmacol. 2015 Oct 5;764:395-403. doi: 10.1016/j.ejphar.2015.06.053. Epub 2015 Jul 14.
Dopamine receptors - IUPHAR Review 13.
Beaulieu JM, Espinoza S, Gainetdinov RR.
Br J Pharmacol. 2015 Jan;172(1):1-23. Review.
Looking beyond the role of glycogen synthase kinase-3 genetic expression on electroretinogram response: what about lithium?
Lavoie J, Hébert M, Beaulieu JM.
Biol Psychiatry. 2015 Feb 1;77(3):e15-e17. doi: 10.1016/j.biopsych.2014.07.024. Epub 2014 Aug 1. No abstract available.
Fluoxetine blocks Nav1.5 channels via a mechanism similar to that of class 1 antiarrhythmics.
Poulin H, Bruhova I, Timour Q, Theriault O, Beaulieu JM, Frassati D, Chahine M.
Mol Pharmacol. 2014 Oct;86(4):378-89. doi: 10.1124/mol.114.093104. Epub 2014 Jul 15.
Distribution and morphological characteristics of striatal interneurons expressing calretinin in mice: a comparison with human and nonhuman primates.
Petryszyn S, Beaulieu JM, Parent A, Parent M.
J Chem Neuroanat. 2014 Sep;59-60:51-61. doi: 10.1016/j.jchemneu.2014.06.002. Epub 2014 Jun 21.
Dopamine D2 receptor relies upon PPM/PP2C protein phosphatases to dephosphorylate huntingtin protein.
Marion S, Urs NM, Peterson SM, Sotnikova TD, Beaulieu JM, Gainetdinov RR, Caron MG.
J Biol Chem. 2014 Apr 25;289(17):11715-24. doi: 10.1074/jbc.M113.544312. Epub 2014 Mar 11.
D1 dopamine receptor coupling to PLCβ regulates forward locomotion in mice.
Medvedev IO, Ramsey AJ, Masoud ST, Bermejo MK, Urs N, Sotnikova TD, Beaulieu JM, Gainetdinov RR, Salahpour A.
J Neurosci. 2013 Nov 13;33(46):18125-33. doi: 10.1523/JNEUROSCI.2382-13.2013.
Stimulation of 5-HT2C receptors improves cognitive deficits induced by human tryptophan hydroxylase 2 loss of function mutation.
Del'Guidice T, Lemay F, Lemasson M, Levasseur-Moreau J, Manta S, Etievant A, Escoffier G, Doré FY, Roman FS, Beaulieu JM.
Neuropsychopharmacology. 2014 Apr;39(5):1125-34. doi: 10.1038/npp.2013.313. Epub 2013 Nov 7.
Spatial intensity distribution analysis (SpIDA): a new tool for receptor tyrosine kinase activation and transactivation quantification.
Barbeau A, Swift JL, Godin AG, De Koninck Y, Wiseman PW, Beaulieu JM.
Methods Cell Biol. 2013;117:1-19. doi: 10.1016/B978-0-12-408143-7.00001-3.
Filters: Manage Filters